AVE 16.7% 0.3¢ avecho biotechnology limited

No turps - we would be in the right poo if Novartis had locked...

  1. 1,053 Posts.
    lightbulb Created with Sketch. 4
    No turps - we would be in the right poo if Novartis had locked us up globally on a pure royalty basis and then just shelved it to get rid of us. I am reliably informed that at this stage there is nothing preventing us from doing deals with whoever we like in the other territories. In fact as soon as we do one I wouldn't be too surprised to see Novartis on the phone fairly quickly. And yes turps that really is the issue there is no clear number 2 - it is Voltaren or a generic - Novartis is pretty much the only named brand with any market penetration. GC is right we need another big pharma that just wants to grab that $1bn market for themselves and I wouldn't have thought it wasn't a very hard sell when we have our own and Novartis' data to prove the claims.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
-0.001(16.7%)
Mkt cap ! $7.923M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $25 10K

Buyers (Bids)

No. Vol. Price($)
66 91668236 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 62801585 14
View Market Depth
Last trade - 10.43am 23/07/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.